Cell bound complement activation products have higher sensitivity than serum C3 and C4 levels in systemic lupus erythematosus 

 -  2014 
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar Washington Hospital Center
<br/><br/><label>Index Terms--Occupation: </label><br/>Medicine/Rheumatology